Shin‐Cheh Chen

8.7k citations
129 papers · 5.0k · 1 hit paper · h-index 35

Impact in

  • Oncology top 1%
    • HER2/EGFR in Cancer Research
    • Lymphatic System and Diseases
    • Cancer-related Molecular Pathways
    • Cancer survivorship and care
    • Cancer Treatment and Pharmacology
    • Breast Cancer Treatment Studies

Papers in

    • HER2/EGFR in Cancer Research 11
    • Cancer survivorship and care 9
    • Cancer Cells and Metastasis 8
    • Cancer Treatment and Pharmacology 7
    • Breast Cancer Treatment Studies 36

Shin‐Cheh Chen

123 papers receiving 4.9k citations

Shin‐Cheh Chen's Hit Papers

MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer 2017 · 1.2k citations
1.2k0+3+6Years since publication2505007501000

Peers

Shin‐Cheh Chen
Comparison fields: 5 of 124
  • Oncology 2.2k
  • Cancer Research 828
  • Pulmonary and Respiratory Medicine 1.6k
  • Pathology and Forensic Medicine 506
  • Genetics 199
Replace Roger von Moos with:
Roger von Moos Switzerland
Franco Nolè Italy
Wei Wei United States
Ingo Bauerfeind Germany
Per Pfeiffer Denmark
Lorenzo Livi Italy
Catherine Van Poznak United States
Louise Provencher Canada
Paul Cottu France
Yazid Belkacémi France
Shin‐Cheh Chen relative to Roger von Moos Switzerland Roger von Moos's profile →
Citations per field
00.5×1.5×1.9×
Roger von Moos · 1×
Citations per year

Countries citing papers authored by Shin‐Cheh Chen

Since Specialization
Citations

This map shows the geographic impact of Shin‐Cheh Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shin‐Cheh Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shin‐Cheh Chen more than expected).

Fields of papers citing papers by Shin‐Cheh Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shin‐Cheh Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shin‐Cheh Chen. The network helps show where Shin‐Cheh Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Shin‐Cheh Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shin‐Cheh Chen Line = papers co-authored together Shin‐Cheh Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.

#Work
1
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
Hit paper breakdown →
20171170
2 2009286
3 2013223
4 1999187
5 2010179
6 2003127
7 2016105
8 2008101
9 199396
10 199691
11 199786
12 201577
13 200870
14 201170
15 201670
16 200369
17 201465
18 201265
19 201561
20
Phosphorylated mTOR expression correlates with poor outcome in early-stage triple negative breast carcinomas.
201260

About Shin‐Cheh Chen

Shin‐Cheh Chen is a scholar working on Oncology, Cancer Research, Surgery, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 129 papers that have together received 5.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (36 papers), Breast Lesions and Carcinomas (17 papers), HER2/EGFR in Cancer Research (11 papers), Advanced Breast Cancer Therapies (11 papers), Cancer survivorship and care (9 papers), Breast Implant and Reconstruction (9 papers), Cancer Cells and Metastasis (8 papers) and Cancer Treatment and Pharmacology (7 papers). The work is most often cited by research in Oncology (2.2k citations), Cancer Research (828 citations), Pulmonary and Respiratory Medicine (1.6k citations), Pathology and Forensic Medicine (506 citations) and Genetics (199 citations). Shin‐Cheh Chen has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Chia‐Siu Wang, Tzu‐Chieh Chao, Miin‐Fu Chen, Mei-Nan Liao, Yun‐Chung Cheung, Yung‐Feng Lo, Jens Huober, Matthew P. Goetz, In Hae Park and Masakazu Toi. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancers, Annals of Surgical Oncology and Biomedical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact